共 443 条
[1]
Marie I(2012)Morbidity and mortality in adult polymyositis and dermatomyositis Curr Rheumatol Rep 14 275-285
[2]
Oddis CV(2013)Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial Arthritis Rheum 65 314-324
[3]
Reed AM(2018)Abatacept in the treatment of adult dermatomyositis and polymyositis: a randomised, phase IIb treatment delayed-start trial Ann Rheum Dis 77 55-62
[4]
Aggarwal R(1987)Reversal of chronic polymyositis following intravenous immune serum globulin therapy JAMA 258 513-515
[5]
Rider LG(1993)A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis N Engl J Med 329 1993-2000
[6]
Ascherman DP(2021)Prospective, double-blind, randomized, placebo-controlled phase III study evaluating efficacy and safety of octagam 10% in patients with dermatomyositis ("ProDERM Study") Medicine (Baltimore) 100 e23677-21
[7]
Levesque MC(2002)Mechanisms of action of IVIg and therapeutic considerations in the treatment of acute and chronic demyelinating neuropathies Neurology 59 S13-89
[8]
Tjarnlund A(2015)Intravenous immunoglobulin in neurology: mode of action and clinical efficacy Nature Rev Neurol 11 80-198
[9]
Tang Q(2011)Mechanisms of action of intravenous immunoglobulin in inflammatory muscle disease Curr Rheumatol Rep 13 192-533
[10]
Wick C(2008)Anti-inflammatory actions of intravenous immunoglobulin Annu Rev Immunol 26 513-1735